February 7, 2023
Royal Pas Reform and HIPRA teams share SmartVac, vaccination expert knowledge

As part of Royal Pas Reform's strategic partnership with HIPRA, the companies recently hosted a joint workshop at HIPRA's head office in Amer, Spain.
The event focused on the SmartVac™ in-ovo vaccination system, chicken immunology and HIPRA vaccines for in-ovo application. It was attended in person by 10 delegates from Royal Pas Reform and 20 from HIPRA, together with more than 50 others participating online.
On the first day, the HIPRA team made presentations on poultry immunology and the different vaccines they develop in the field of in-ovo. HIPRA's latest in-ovo vaccine for coccidiosis in broilers (Evanovo®) is suitable for use with SmartVac™ since it requires injection into the amniotic liquid, Pas Reform said.
The group then visited the SmartVac demo unit in the HIPRA research facilities and opened vaccinated eggs in the lab to evaluate the site of injection (SOI): the specific location of release of the vaccine within an 18.5-day-old hatching egg. The day concluded with a visit to the SmartVac operational unit in the hatchery nearby for all to watch the machine working in real-time.
Following a tour of HIPRA's state-of-the-art HQ and R&D facilities at the start of day 2, the specialist Pas Reform Academy team gave presentations on embryology, hatch window, embryonic mortality and data management in the hatchery.
Royal Pas Reform delegate Erwin Prinzen said: "HIPRA and Royal Pas Reform are very similar kind of companies. These events are both incredibly instructive and also very important for developing good ties between the two organisations. It ensures that we continue to collaborate in such a way that the synergies between the companies are always directed towards providing better and more effective experiences for our clients. By sharing knowledge and experiences, we will be able to better assist our customers."
- Pas Reform